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HAEMORRHAGE from cesophageal varices is a dreaded and frequently fatal
complication of portal hypertension. In patients with cirrhosis the mortality
within one year of the first hxmorrhage is from 25-75 per cent. (Britton, 1958;
Baker et al., 1959; Palmer, 1951; Peskin and Miller, 1964). The most effective
way of preventing recurrent bleeding is reduction of the portal pressure by some
form of portal-systemic shunt, but unfortunately there are patients where this is
impractical. The large variety of other recommended procedures in this situation
is a sure indication that no one method is entirely satisfactory. Indeed Mikkelson
and Pattison (1959) considered that if a venous shunt could not be constructed,
no satisfactory alternative operative procedure was available for the treatment
of bleeding from cesophageal varices.
There are a large number of patients in whom a portacaval shunt is impossible
or inadvisable.
(1) A situation where shunt is contra-indicated is in the cirrhotic patient where
advanced age, significant jaundice, resistant ascites, hypo-albuminaemia or
a previous history of liver failure are present. Although these contra-
indications to shunting are widely recognised, the treatment of those
"surgical rejects" is less well documented so that methods helpful in the
management of these cases are of some importance.
(2) When varices are secondary to an extrahepatic block the portal vein is
rarely available for the construction of a shunt. As many as 70 per cent.
of the patients with portal vein thrombosis have their first haemorrhage
before the age of 7 years (Aracari and Lynn, 1961), but unfortunately the
conventional lieno-renal shunts are unsatisfactory before the age of 10 years,
80 per cent. becoming thrombosed (Clatworthy et al., 1964). It is in this
extrahepatic group that Shaldon and Sherlock (1962) advocate medical
management when portacaval shunt is impractical.
(3) In the cirrhotic patient, surgery as an emergency procedure carries a
mortality of more than 50 per cent. Both emergency portacaval shunt
(Walker, 1960; Sullivan et al., 1960; Patton, 1963; Brick and Palmer, 1964),
and trans-cesophageal ligation of varices (Read et al., 1960; Palmer, 1961;
Britton and Crile, 1963) carry this prohibition mortality in most centres.
Indeed Crile, one of the surgeons who introduced the operation of trans-
cesophageal ligation in the emergency treatment of bleeding varices, recently
110stated that non-surgical measures of controlling active bleeding in cirrhotic
patients are preferable to emergency surgical methods (Birtton and Crile,
1963).
DIAGNOSIS.
When massive gastro-intestinal bleeding occurs an early and accurate location
of the site and nature of the bleeding is essential. It is dangerous to assume that
the bleeding lesion of the patient with known portal hypertension is aesophageal
varices. The history and physical examination remain the keystone in diagnosis.
Barium studies of the cesophagus, stomach, and duodenum should be undertaken
routinely as an emergency procedure.
Where the diagnosis remains in doubt liver function tests, cesophagoscopy and
gastroscopy, and measurement of the intrasplenic pressure add further information.
TREATMENT.
1. General Measures.
(a) SEDATION.-All the common hypnotics, sedatives and analgesics may be
poorly tolerated by the patient with cirrhosis and should either not be
used or used with extreme caution. In the agitated patient, where sedation
is considered imperative, small doses of pethidine or a short chain
barbiturate such as phenobarbitone are the safest drugs to employ.
(b) BLOOD TRANSFUSIoN.-No matter how trivial the initial haemorrhage may
appear, it is important to set up an infusion and cross match a very large
quantity of blood. Fresh blood should be used because of the frequent
deficiency of certain coagulation factors in the presence of cirrhosis,
particularly prothrombin, factors V and VII and Christmas factor. Also
25 mgs. of Vitamin K,-oxide (phytomenadione) should be given daily to
try and improve the prothrombin concentration. Where large quantities
of citrated blood are transfused it is important to give 10 ccs. of 10
per cent. calcium gluconate intravenously for every litre of blood given.
(c) THERAPY TO PIREVENT HEPATIC COMIA.-Even in the absence of any signs
of impending coma, all these cirrhotic patients should be treated as potential
cases of portal-systemic encephalopathy. The absorption of ammonia from
the breakdown of blood in the gut is reduced by purgation, enemas, and
neomycin therapy.
2. Vasopressin ("Pitressin").
Posterior pituitory estract lowers the portal pressure probably by constriction
of the splanchnic arteriorlar bed. This temporary reduction in pressure presumably
allows hoemostasis at the bleeding point. Vasopressin ("pitressin") is given intra-
venously in a dosage of 20 units in 100 ccs. of 5 per cent. dextrose over a period
of 10-20 mins. This can be repeated four-hourly on a few occasions, but un-
fortunately the response diminishes with repeated infusions (Shaldon and Sherlock,
1960). Abdominal colic, evacuation of the bowel and facial pallor are fairly
constant side effects, and, indeed, if they are absent, one should suspect that the
"pitressin" being used is inactive.
1113. (Esophageal Tamponade.
If bleeding continues cesophageal tamponade is employed, using some form
of distensible balloon of which the best known is that introduced by Sengstaken
and Blakemore (1950). We have found this to be a life-saving, though temporary
measure. A new tube should be used for each patient and both balloons thoroughly
tested for leaks before insertion. Persistence of bleeding after intubation indicates
that the tube is improperly placed or that bleeding is coming from a site other
than the cesophagus, such as gastric varices or peptic ulcer. It is probable,
however, that gastric varices may be controlled in some patients if the gastric
balloon is pulled firmly against the upper part of the fundus prior to inflation
of the cesophageal balloon. Once the cesophageal balloon has been inflated the
patient must not be left unattended.
In a small series of 30 intubations we have failed to control the bleeding in
only two cases, one with proven gastric varices and one with suspected gastric
varices. We failed to pass the tube in one other patient due to lack of co-
operation. In another recent series, bleeding was controlled in 14 out of 17
intubations (Macpherson, 1964).
The only complication in our series was failure of deflation of the gastric
balloon on one occasion which was overcome by injecting trilene into the balloon,
causing it to burst. Undue prominence has been given to the hazards of the
procedure and in one reported series of 50 patients only 20 per cent. were free
from complications (Conn, 1958). Recent experience, however, indicates that the
hazards can be greatly reduced by appropriate measures. Ulceration of the
cesophagus or pharynx rarely occurs unless the tube is left in place for prolonged
periods and traction applied (Bonn, 1958; Read et al., 1960), so that our policy
has been to leave the tube for a maximum of 24 to 48 hours and never use
traction. Ulceration of the nares is due to improper placement of the tube at
the nostril and is aggravated by unnecessary traction. Aspiration of gastric
contents into the bronchi during passage of the tube is unlikely unless the patient
is in coma, and aspiration of swallowed secretions after inflation of the balloons
can be reduced by the use of a four-lumen tube with a pharyngeal opening for
suction. We have found that atropine is helpful in reducing the troublesome
secretion of saliva. If the cough reflex is absent the patient is nursed in the
three-quarter prone position with the foot of the bed elevated. Respiratory
obstruction due to proximal slipping of the tube is unlikely in the absence of
traction, and, anyhow, should not have a fatal outcome if the nurse in attendance
is fully instructed in the care of the tube. Writing recently, Brick and Palmer
(1964) claimed that the Sengstaken-Blakemore tube was the most "reliable
emergency approach available."
4. injection of the Varices.
The treatment of oesophageal varices by the injection of sclerosing agents
through an cesophagoscope was first described by Crafoord and Frenckner in
1939. Although many consider the method unsatisfactory, Patterson, in 1948,
said, "To my knowledge, no other method has been proposed which can so
112effectively protect these patients bleeding from cesophageal varices from re-
currence of hematemesis." Although we do not consider it the routine treatment
of bleeding varices in all cases, it is particularly useful in those patients where
surgery is contra-indicated.
The technique of Macbeth (1955) is used with a few minor modifications.
The largest cesophagoscope which can be passed with safety is used, since a
small-bore instrument fails to distend the varices prior to injection or compress
them after injection. Although the most important site of injection is at the
extreme lower end of the cesophagus, it is sometimes more convenient to inject
the proximal varices first, so that the instrument can compress the puncture sites
and prevent bleeding while the more distal varices are injected. We now use
much greater quantities of the sclerosing agent than previously, and have injected
up to 35 ccs. of ethyl oleamine oleate with no untoward effects. A short period
of cesophageal tamponade after injection prevents any bleeding from needle
punctures and probably aids in the sclerosis of the vessels.
Thirty-seven patients at the Royal Victoria Hospital, Belfast, 22 with cirrhosis
and 15 with extrahepatic block, have received a total of 72 injections, one patient
receiving as many as nine. In the extra-hepatic group the ages ranged from 7
months to 39 years with a mean age of 19. In the patients with cirrhosis the
range was from 16 to 75 with a mean 51 years. In the non-cirrhotic group
injection therapy resulted in relief from bleeding for as long as 4j years with
an average relief of 14 months. Trusler and his colleagues (1962) give similar
results. On the other hand, in the cirrhotic group, the maximum freedom from
bleeding was 2 years with an average of only 6 months. After injection therapy
episodes of bleeding not only become less frequent but also tend to be less
severe and on repeat cesophagoscopy the varices are of smaller calibre (Samson
and Foree, 1942; Moersch, 1947). In one of our patients, with cavernous
transformation of the portal vein, who had suffered 12 major haematemesis
between the ages of 6 and 16, no varices were seen on cesophagoscopy 2 years
after completion of a series of 6 injections. In patients coming to autopsy after
injection therapy, thrombosis of the veins (Samson and Foree, 1942; Fearnon and
Sass-Kortsak, 1956) and perivenous fibrosis with thickening of the intima
(Moersch, 1947) have been noted.
Injection therapy is a minor procedure and is remarkably free of complications.
Some mild retrosternal pain, pyrexia, and tachycardia are usual for 24-48 hours
after injection. One 18-year-old girl with portal vein thrombosis developed a
deep venous thrombosis of the leg four days after injection of her varices. It
is emphasised that injection therapy is not used as a definitive treatment but is
used to tide the patient over until a shunt becomes a practical procedure.
5. "Urgent" Portacaval Shunt.
There are many reasons why emergency portacaval shunts have carried such
a high mortality in the past. They were usually performed as a last resort in
the patient who continued to bleed in spite of all available medical measures.
Not infrequently this persistent bleeding was the result of a breakdown in the
113coagulation mechanism secondary to advanced hepato-cellular failure. Also,
because of the hamorrhage, the gut was full of blood which is a rich source of
ammonia and a major factor in the production of coma. Alterations in blood
volume, changes in electrolytes, hypotension, and general anasthesia were
probably contributing factors to a fatal outcome. Thus 7 of 9 patients who had
emergency shunts in the Royal Victoria Hospital, Belfast, since 1948 died within
an average of four days from the operation.
However, if bleeding recurs after application of all the usual emergency
conservative measures, surgery must be undertaken if the patient is to survive.
In this situation an "urgent" rather than an "emergency" portacaval shunt is
probably the procedure of choice. With a Sengsktken-Blakemore tube in place
for forty-eight hours prior to the operation, no further blood loss can occur and
time is available for restoration of the blood volume and correction of any
electrolyte disturbances. It is also possible to evacuate the accumulated blood
from the bowel by purgation and enemas, and to sterilise the gut with neomycin,
thus reducing the chance of portal-systemic encephalopathy subsequent to
shunting. Some workers have reported a lower mortality for this type of "urgent"
portacaval shunt than for transcesophageal ligation (Palmer, 1961; Shaldon and
Walker, 1962). Recently two of our patients required "urgent" portacaval shunts
because of persistent bleeding and both had successful outcome.
SUMMARY.
Portal systemic shunt operations are impossible or unwise in some patients
with portal hypertension.
Conservative measures, including the use of cesophageal tamponade and injection
of varices are advocated in order to tide over the young patient with obliteration
of the portal vein, until the age of 10 years, when lieno-renal shunt carries a
greater chance of success.
Conservative management is also preferable in the episode of acute bleeding
in the presence of cirrhosis, or where a shunt is contra-indicated because of
advanced age, jaundice, procoma and hypoalbuminuria.
Injection of varices is put forward, not as an alternative method of treatment
but as an adjuvant to the medical and surgical methods at present in vogue.
Where injection therapy fails to control the episodes of acute bleeding "urgent"
portacaval shunt is preferable to a direct surgical attack on the varices.
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